← Back to all trials
Recruiting
NCT05750381
Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.
Conditions: Microbial Colonization
Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 20
Sponsor: BLIS Technologies Limited
Location: New Zealand
Summary
The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the elbow and back of forearm in a topical balm format in healthy adults.
Eligibility Criteria
Inclusion Criteria:In general good health 18 - 80 years of age.Practice good general body hygieneExclusion Criteria:Have a history of autoimmune disease or are immunocompromised.Are on concurrent antibiotic therapy or regular antibiotic use within the last 1 week.People with allergies or sensitivity to dairy.People with an open wound on the Blis Q24 application sites.
Source: ClinicalTrials.gov (NCT05750381). StuddyBuddy aggregates publicly available trial information.